Cure Alzheimer’s Fund Research Grants support innovative scientific research targeting the mechanisms, biomarkers, and potential treatments for Alzheimer’s disease.
Funder: Cure Alzheimer's Fund
Due Dates: Rolling (Letters of Inquiry and proposals accepted year-round)
Funding Amounts: Typical award: $201,250/year (up to $175,000 direct + 15% indirects); duration: 1–2 years
Summary: Supports innovative research projects that accelerate discovery of a cure or disease-modifying treatment for Alzheimer’s disease.
Key Information: LOIs required; unsolicited full proposals not accepted; open to both academic and eligible for-profit researchers.
Cure Alzheimer’s Fund supports bold, high-impact scientific investigations with strong potential to advance prevention, risk reduction, and disease-modifying treatments for Alzheimer’s disease. The program emphasizes foundational, translational, and drug discovery research—including genetic risk factors, biomarkers, novel Alzheimer’s genes, immune response, enabling technologies, and clinical trial design. Projects must directly address Alzheimer’s disease, and the fund prioritizes approaches that meaningfully contribute to eventual therapies or a cure.